Examining the clinical impact of rapid multiplex polymerase chain reaction‐based diagnostic testing for bloodstream infections in a national cohort of the Veterans Health Administration
- 21 December 2022
- journal article
- research article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 43 (1) , 24-34
Abstract
Study Objective: Bloodstream infections (BSIs) are a significant cause of mortality. Use of a rapid multiplex polymerase chain reaction‐based blood culture identification panel (BCID) may improve antimicrobial utilization and clinical outcomes by shortening the time to appropriate therapy and de‐escalating antibiotics among patients on overly broad‐spectrum empiric therapy. The effect of BCID on clinical outcomes across varying institutional antimicrobial stewardship program (ASP) practices is unclear. This study evaluated clinical outcomes associated with the “real‐world” implementation of BCID in a national health system with varying ASP practices.Design: National, multicenter, retrospective, pre–post quasi‐experimental study of hospitalized patients admitted from 2015 to 2020 to VHA facilities, which introduced the BCID for ≥1 year.Setting: United States Veterans Health Administration (VHA) hospitals with BCID.Patients: Hospitalized VHA patients with ≥1 blood culture positive for bacteria featured on the BCID panel.Intervention: Comparison of outcomes between the pre‐ and post‐BCID implementation groups.Measurements: Outcomes evaluated included early antimicrobial de‐escalation within 48 h, defined as reduction in antimicrobial spectrum scores, time to appropriate therapy, and 30‐day mortality.Main Results: A total of 4138 patients (pre‐BCID, n = 2100; post‐BCID, n = 2038) met the study criteria. Implementation of BCID was associated with significant improvements in early antimicrobial de‐escalation (34.6%: pre‐BCID vs. 38.1%: post‐BCID; p = 0.022), which persisted after adjusting for other covariates (adjusted risk ratio [aRR], 1.11; 95% confidence interval [CI], 1.02–1.20; p = 0.011). Median time to appropriate therapy was shorter in the post‐BCID implementation group relative to the pre‐BCID group (9 h: pre‐BCID vs. 8 h: post‐BCID, respectively, p = 0.005), and a greater percentage of patients received early appropriate antimicrobial therapy within 48 h in the post‐BCID implementation group (91.7%: pre‐BCID vs. 93.8%: post‐BCID; p = 0.008). In the multivariable regression analysis, BCID implementation was significantly associated with a higher likelihood of appropriate therapy within 48 h (aRR, 1.02; 95% CI, 1.01–1.08; p = 0.020). There was no difference in 30‐day mortality between groups overall (12.6% pre‐BCID vs. 11.2% post‐BCID; p = 0.211).Conclusions: In a “real‐world” clinical setting, the implementation of BCID was associated with clinical improvements in antimicrobial utilization. The BCID platform may serve as a useful adjunct for BSI management in facilities with ASP.Keywords
Funding Information
- bioMérieux
This publication has 26 references indexed in Scilit:
- Clinical and economic impact of antimicrobial stewardship interventions with the FilmArray blood culture identification panelDiagnostic Microbiology and Infectious Disease, 2016
- Antimicrobial de-escalation of treatment for healthcare-associated pneumonia within the Veterans Healthcare AdministrationJournal of Antimicrobial Chemotherapy, 2015
- Randomized Trial of Rapid Multiplex Polymerase Chain Reaction–Based Blood Culture Identification and Susceptibility TestingClinical Infectious Diseases, 2015
- Description and validation of a spectrum score method to measure antimicrobial de-escalation in healthcare associated pneumonia from electronic medical records dataBMC Infectious Diseases, 2015
- Review of Rapid Diagnostic Tests Used by Antimicrobial Stewardship ProgramsClinical Infectious Diseases, 2014
- Development of an Antibiotic Spectrum Score Based on Veterans Affairs Culture and Susceptibility Data for the Purpose of Measuring Antibiotic De-Escalation: A Modified Delphi ApproachInfection Control & Hospital Epidemiology, 2014
- Clinical Evaluation of the FilmArray Blood Culture Identification Panel in Identification of Bacteria and Yeasts from Positive Blood Culture BottlesJournal of Clinical Microbiology, 2013
- Incidence of bloodstream infection: a review of population-based studiesClinical Microbiology and Infection, 2013
- Rapid identification of pathogens from positive blood cultures by multiplex polymerase chain reaction using the FilmArray systemDiagnostic Microbiology and Infectious Disease, 2012
- Predictors of Mortality in Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae : Importance of Inadequate Initial Antimicrobial TreatmentAntimicrobial Agents and Chemotherapy, 2007